MTOR and chordoma: Whilst results of mTOR inhibitors have been disappointing in chordoma [7, 15], one prospective study evaluated the combination of imatinib and everolimus in 43 adults with advanced chordoma and identified a response rate of 20.9% by the Choi criteria with some association of response to activation of the mTOR pathway [19].